Overview

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Eye Center and The Eye Foundation for Research in Ophthalmology
Treatments:
Cysteamine
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- patients with confirmed diagnosis of nephropathic cystinosis

- leucocyte cystine concentration level of more than 2.0 nmol half-cystine/ mg protein

- clinical evidence of tissue deposition of cystine and tissue damage due to cystinosis

Exclusion Criteria:

- Allergy to cysteamine